Patents by Inventor Richard Brian GAYNOR

Richard Brian GAYNOR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION OF AN ANTI-VEGFR-2 ANTIBODY AND AN ANTI-PD-L1 ANTIBODY FOR THE TREATMENT OF CANCER
    Publication number: 20200062850
    Abstract: The present disclosure relates to a combination of anti-human VEGFR-2 antibodies (Ramucirumab) and anti-human PD-L1 (durvalumab) antibodies for treating certain disorders, including advanced gastric or gastroesophageal junction adenocarcinomas, non-small cell lung cancer, and hepatocellular carcinomas. Sequences 3 & 4 represent Ramucirumab VL and VH; Sequences 7 & 8 those of Durvalumab.
    Type: Application
    Filed: October 27, 2017
    Publication date: February 27, 2020
    Inventors: Richard Brian GAYNOR, Maria KARASARIDES
  • COMBINATION OF RAMUCIRUMAB AND PEMBROLIZUMAB FOR THE TREATMENT OF CERTAIN CANCERS
    Publication number: 20190183972
    Abstract: The present disclosure relates to a combination of ramucirumab and pembrolizumab and methods of using the combination to treat certain disorders, such as non-small cell lung cancer, urothelial cancer, biliary tract cancer, and advanced gastric or gastroesophageal junction adenocarcinoma.
    Type: Application
    Filed: May 26, 2017
    Publication date: June 20, 2019
    Inventor: Richard Brian GAYNOR